Our | Products


Leunib 100 mg





THERAPEUTIC AREA: Oncology / Hematology
ACTIVE PRINCIPLE: Dasatinib
PRESENTATION: 100 mg x 30 coated tablets
INDICATION:

  • Acute Lymphoblastic Leukemia
  • Chronic Myeloid Leukemia